"Our nomination provides numerous examples of these risks, including unknown impurities, peptide-related impurities, incorrect strengths, and even instances where no semaglutide was present in the product at all," Novo Nordisk spokesperson Jamie Bennet wrote in an email to NPR
But interesting biology and plausible mechanisms are where drug development begins, not ends
"So if GLP-1s have the potential to decrease cancer risks outside obesity alone, those patients may stand to benefit," she says
How Much Weight Can I Lose With Semaglutide
If youre honest with yourself about whether youll actually food-track daily, exercise 5-6 days weekly, and maintain rigid meal planning for months at a time, youll know if this path is realistic
A former head of the US Food and Drug Administration cut his body fat in half using GLP-1 drugs